Skip to main content
. 2018 Apr 19;13(4):e0196076. doi: 10.1371/journal.pone.0196076

Table 2. Results of the survey.

Midwives GPs Pediatricians * P value
N = 291 N = 206 N = 154
Early recognition of jaundice To palms and soles
Before 24 h of age
44 (15)
112 (39)
102 (49)
39 (19)
77 (50)
60 (39)
0.01
Pale-colored feces
Between 24 h to 14 d
Bilirubin levels of > 10 mg/dL
52(18)
82 (28)
1 (0)
24 (12)
22 (11)
19 (9)
6 (4)
3 (2)
8 (5)
Predischarge bilirubin measurement Yes, mostly 48 (17) 53 (26) 12 (8) 0.01
Yes, if jaundice present 147 (50) 112 (54) 100 (65)
No 96 (33) 41 (20) 42 (27)
Specific guideline used IHM guideline 156 (54) 55 (27) 10 (7) 0.01
WHO guideline 41 (14) 94 (46) 7 (4)
AAP guideline 3 (1) 7 (3) 129 (84)
NICE guideline 0 (0) 2 (1) 3 (2)
No guideline 84 (29) 48 (23) 0
Other 7 (2) 0 (0) 5 (3)
Guideline access Yes 205 (71) 142 (69) 80 (52) 0.01
Not easy 85 (29) 64 (31) 74 (48)
Problems in management Education 112 (38) 22 (11) 49 (32) 0.01
Diagnostics 15 (5) 44 (21) 32 (21)
Therapy 113 (39) 97 (47) 38 (24)
Facilities 51 (18) 43 (21) 35 (23)
Case scenario Discharge and follow- up 18 (6) 19 (9) 7 (4) 0.01
Lab. tests bilirubin + BG 128 (44) 117 (57) 83 (54)
Cancel discharge and start phototherapy 25 (9) 21 (10) 62 (40)
Refer to pediatrician 120 (41) 49 (24) 2 (1)
Discharge (LOS) ≤ 24 h 163 (56) 85 (41) 11 (7) 0.01
25–48 h 99 (34) 111 (54) 45 (29)
> 48 h 29 (10) 10 (5) 98 (64)
First follow-up 24 h 14 (5) 10 (5) 0 (0) 0.01
25–48 h 107 (36) 49 (24) 9 (6)
49–72 h 87 (30) 83 (40) 66 (43)
>72 h 83 (29) 64 (31) 79 (51)

Data are numbers and (percentages).

* P values are the results of Pearson’s chi-square tests between the three types of health professionals in all categories of the variables.

Abbreviations: IHM—Indonesian Health Ministry, WHO -World Health Organization, AAP -American Academy of Pediatrics, NICE—National Institute for Health and Care Excellence, BG—blood group, rhesus and Coombs testing, LOS—length of stay.